Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences

Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest

(2010) Matthias Thielmann et al.   BASIC RESEARCH IN CARDIOLOGY

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

(2010) Derek J. Hausenloy et al.   BASIC RESEARCH IN CARDIOLOGY

The neural and humoral pathways in remote limb ischemic preconditioning

(2010) Shiang Y. Lim et al.   BASIC RESEARCH IN CARDIOLOGY

Adeno-associated virus: a key to the human genome?

(2010) Els Henckaerts et al.   Future Virology

Cardioselective nitric oxide synthase 3 gene transfer protects against myocardial reperfusion injury

(2009) Zsolt Szelid et al.   BASIC RESEARCH IN CARDIOLOGY

Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by Upregulating Heme Oxygenase-1 Via a Nuclear Factor-κB-Dependent Pathway

(2009) Qianhong Li et al.   CIRCULATION

AAV as a Gene Transfer Vector for the Treatment of Neurological Disorders: Novel Treatment Thoughts for ALS

(2009) Mark Hester et al.   CURRENT GENE THERAPY

Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart

(2009) Soban Umar et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Exercise Preconditioning of the Myocardium

(2009) Andreas N. Kavazis   SPORTS MEDICINE

Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy

(2008) Tetsuji Miura et al.   BASIC RESEARCH IN CARDIOLOGY

Cardioprotection

(2008) Gerd Heusch et al.   CIRCULATION